Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
A Kröker, M Tirzīte - Respiratory Research, 2021 - Springer
Background The COVID-19 pandemic has affected the world extraordinarily. This disease
has a potential to cause a significantly severe course of disease leading to respiratory …
has a potential to cause a significantly severe course of disease leading to respiratory …
COVID-19: A review of the proposed pharmacological treatments
S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …
Old and re-purposed drugs for the treatment of COVID-19
SS Jean, PR Hsueh - Expert review of anti-infective therapy, 2020 - Taylor & Francis
Introduction: The coronavirus disease 2019 (COVID-19) caused by the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed since December 2019. It …
Treatment of COVID-19: a review of current and prospective pharmacotherapies
E Quek, H Tahir, P Kumar… - British Journal of …, 2021 - magonlinelibrary.com
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and …
syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and …
Repurposing existing drugs for the treatment of COVID-19
The rapid global spread and significant mortality associated with the coronavirus disease
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral …
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral …
[HTML][HTML] Pharmacologicaltreatment of COVID-19: lights and shadows
F Menzella, M Biava, C Barbieri, F Livrieri… - Drugs in …, 2020 - ncbi.nlm.nih.gov
At the end of December 2019, a novel coronavirus, the severe acute respiratory syndrome
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …
COVID‐19: a review of therapeutics under investigation
JC Crosby, MA Heimann, SL Burleson… - Journal of the …, 2020 - Wiley Online Library
The COVID‐19 outbreak has disrupted global health care networks and caused thousands
of deaths and an international economic downturn. Multiple drugs are being used on …
of deaths and an international economic downturn. Multiple drugs are being used on …
Current pharmacological treatments for SARS-COV-2: A narrative review
G Nittari, G Pallotta, F Amenta, SK Tayebati - European Journal of …, 2020 - Elsevier
The novel coronavirus, later identified as SARS-CoV-2, originating from Wuhan in China in
November 2019, quickly spread around the world becoming a pandemic. Despite the …
November 2019, quickly spread around the world becoming a pandemic. Despite the …
[HTML][HTML] Medical management of COVID-19: evidence and experience
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
Advances in the possible treatment of COVID-19: A review.
P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …